Literature DB >> 14557061

Complete DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain.

Li Zhang1, Wei-Jen Lin, Shengwen Li, K Roger Aoki.   

Abstract

BOTOX is manufactured with the purified native 900-kDa type A neurotoxin complex from Clostridium botulinum type A-Hall (Allergan) strain. This complex is composed of the botulinum neurotoxin (BoNT) and several toxin associated proteins known as the hemagglutinins (HAs) and the non-toxic non-hemagglutinin protein (NTNH). We describe here the complete gene sequences of the BoNT complex of type A-Hall (Allergan) strain. Using a polymerase chain reaction-based approach, we sequenced six open reading frames (ORFs) encoding BoNT (1296 amino acids), the toxin-associated proteins: HA70, 625 aa; HA17, 147 aa; HA34, 291 aa; NTNH, 1193 aa; and the regulatory component botR/OrfX, 178 aa. Comparative alignments of the amino acid sequence of BoNT/A shows a 98-100% sequence identity among different strains of the type A, except for the Kyoto-F strain (90%), whereas the sequence identity between BoNT/A and other toxin serotypes is only 30.4-39.1%. Similar to the neurotoxin, the toxin-associated proteins and botR from type A-Hall strain also share more than 95% identity to the homologous proteins found in type A-NCTC2916 strain. Among all the toxin associated proteins, NTNHs and HA70s are the most conserved with 65-87% identity across different serotypes. On the other hand, HA34s, present only in serotypes A-D, show greater diversity than all other toxin-associated proteins; HA34/A has 90% identity to HA34/B and only approximately 35% identity to HA34/C and HA34/D. Relatively higher sequence identity ( approximately 60%) is seen in HA17 and botR of Hall A when compared to their counterparts in serotypes C or D. Of all proteins within the toxin complex, NTNH and HA70 have the highest degree of conservation across serotypes and this may underscore a critical role for these proteins in the formation of the complexes. Physiologically, different duration of action in different serotypes may be due to different modifications of toxins by neuronal enzymes, which lead to different compartmentalization of different toxins. Computer-assisted motif analysis reveals that toxins contain several potential sites for phosphorylation by casein kinase II, protein kinase C, tyrosine kinases, glycogen synthase kinase 3, cGMP dependent protein kinase (PKG) that are well conserved. The reported sequence information for type A-Hall strain will potentially facilitate elucidation of the toxin interactions with the nontoxin proteins in the complex.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557061     DOI: 10.1016/s0378-1119(03)00792-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  12 in total

1.  Analysis of genomic differences among Clostridium botulinum type A1 strains.

Authors:  Ping-Ke Fang; Brian H Raphael; Susan E Maslanka; Shuowei Cai; Bal Ram Singh
Journal:  BMC Genomics       Date:  2010-12-23       Impact factor: 3.969

2.  Genetic diversity among Botulinum Neurotoxin-producing clostridial strains.

Authors:  K K Hill; T J Smith; C H Helma; L O Ticknor; B T Foley; R T Svensson; J L Brown; E A Johnson; L A Smith; R T Okinaka; P J Jackson; J D Marks
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

3.  Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Authors:  T J Smith; J Lou; I N Geren; C M Forsyth; R Tsai; S L Laporte; W H Tepp; M Bradshaw; E A Johnson; L A Smith; J D Marks
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Characterization of botulinum progenitor toxins by mass spectrometry.

Authors:  Harry B Hines; Frank Lebeda; Martha Hale; Ernst E Brueggemann
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

5.  Differentiation of the gene clusters encoding botulinum neurotoxin type A complexes in Clostridium botulinum type A, Ab, and A(B) strains.

Authors:  Giovanna Franciosa; Francesca Floridi; Antonella Maugliani; Paolo Aureli
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

6.  Comparison of assembled Clostridium botulinum A1 genomes revealed their evolutionary relationship.

Authors:  Virginia Ng; Wei-Jen Lin
Journal:  Genomics       Date:  2013-12-22       Impact factor: 5.736

7.  Subunit stoichiometry of the Clostridium botulinum type A neurotoxin complex determined using denaturing capillary electrophoresis.

Authors:  Michael A Lietzow; Elizabeth T Gielow; Denise Le; Jifeng Zhang; Marc F Verhagen
Journal:  Protein J       Date:  2008-12       Impact factor: 2.371

8.  Consistent biochemical data are essential for comparability of botulinum toxin type A products.

Authors:  Andy Pickett
Journal:  Drugs R D       Date:  2011

9.  Cloning, expression, purification, and characterization of biologically active recombinant hemagglutinin-33, type A botulinum neurotoxin associated protein.

Authors:  Yu Zhou; Sowmya Paturi; Paul Lindo; Suzanne M Shoesmith; Bal Ram Singh
Journal:  Protein J       Date:  2007-01       Impact factor: 4.000

10.  Attomolar detection of botulinum toxin type A in complex biological matrices.

Authors:  Karine Bagramyan; Jason R Barash; Stephen S Arnon; Markus Kalkum
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.